Replies to post #126718 on Biotech Values

[mcbio]

I guess we've all forgotten about Millennium's MLN2704, the PSMA-targeting ADC (from IMGN) which was in the clinic a decade ago and never got anywhere.

Hopefully this turns out to be an issue of the drug, not the target, and an SGEN PSMA-targeting ADC turns out to be > than an IMGN PSMA-targeting ADC. ; )